Ivana Okić Đorđević

Dr. Ivana Okić Đorđević

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Life Sciences
Verified
Journal Article
Closed access
Drenka TrivanovićDrenka Trivanović
Drenka Trivanović
AJAleksandra Jaukovic
Aleksandra Jaukovic
BPBranka Popović
Branka Popović
Jelena KrsticJelena Krstic
Jelena Krstic
SMSlavko Mojsilović
Slavko Mojsilović
DBDiana S. Bugarski
Diana S. Bugarski

1 January 2013 in Srpski arhiv za celokupno lekarstvo
Verified
Journal Article
Open access
PDF file
Drenka TrivanovićDrenka Trivanović
Drenka Trivanović
JKJelena Kocic
Jelena Kocic
SMSlavko B. Mojsilovic
Slavko B. Mojsilovic
AKAleksandra Krstic
Aleksandra Krstic
Vesna IlićVesna Ilić
Vesna Ilić
DBDiana Bugarski
Diana Bugarski
Introduction. Mesenchymal stem cells (MSCs) are a promising tool for regenerative medicine, but due to the heterogeneity of their populations, different sources and isolation techniques, the characteristics defining MSCs are inconsistent. Objective. The aim of this study was to compare the characteristics of MSCs derived from two different human tissues: peripheral blood (PB-MSCs) and umbilical cord Wharton?s Jelly (UC-MSCs). Methods. The PB-MSC and UC-MSC were isolated by adherence to plastic after gradient-density separation or an explant culture method, respectively, and compared regarding their morphology, clonogenic efficiency, proliferating rates, immunophenotype and differentiation potential. Results. MSCs derived from both sources exhibit similar morphology, proliferation capacity and multilineage (osteogenic, chondrogenic, adipogenic and myogenic) differentiation potential. Differences were observed in the clonogenic capacity and the immunophenotype, since UC-MSCs showed higher CFU-F (colony-forming units-fibroblastic) cloning efficiency, as well as higher embryonic markers (Nanog, Sox2, SSEA4) expression. When additional surface antigens were analyzed by flow cytometry (CD44, CD90, CD105, CD33, CD34, CD45, CD11b, CD235a) or immunofluorescent labeling (vimentin, STRO-1 and ?-smooth muscle actin), most appeared to have similar epitope profiles irrespective of MSC source. Conclusion. The results obtained demonstrated that both MSCs represent good alternative sources of adult MSCs that could be used in cell therapy applications.

1 February 2015 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
Jelena KrsticJelena Krstic
Jelena Krstic
HOHristina Obradović
Hristina Obradović
AJAleksandra Jaukovic
Aleksandra Jaukovic
IĐIvana Okić Đorđević
Ivana Okić Đorđević
Drenka TrivanovićDrenka Trivanović
Drenka Trivanović
DBDiana Bugarski
Diana Bugarski

24 January 2016 in IUBMB Life
Verified
Journal Article
Open access
PDF file
Drenka TrivanovićDrenka Trivanović
Drenka Trivanović
AJAleksandra Jaukovic
Aleksandra Jaukovic
Jelena KrsticJelena Krstic
Jelena Krstic
SNSrdjan Nikolić
Srdjan Nikolić
IĐIvana Okić Đorđević
Ivana Okić Đorđević
DBDiana S. Bugarski
Diana S. Bugarski
Mesenchymal stem cells from human adipose tissue (hASCs) are proposed as suitable tools for soft tissue engineering and reconstruction. Although it is known that hASCs have the ability to home to sites of inflammation and tumor niche, the role of inflammatory cytokines in the hASCs‐affected tumor development is not understood. We found that interferon‐γ (IFN‐γ) and/or tumor necrosis factor‐α (TNF‐α) prime hASCs to produce soluble factors which enhance MCF‐7 cell line malignancy in vitro. IFN‐γ and/or TNF‐α‐primed hASCs produced conditioned media (CM) which induced epithelial to mesenchymal transition (EMT) of MCF‐7 cells by reducing E‐Cadherin and increasing Vimentin expression. Induced EMT was accompanied by increased invasion, migration, and urokinase type‐plasminogen activator (uPA) expression in MCF‐7 cells. These effects were mediated by increased expression of transforming growth factor‐β1(TGF‐β1) in cytokines‐primed hASCs, since inhibition of type I TGF‐β1 receptor on MCF‐7 cells and neutralization of TGF‐β1 disabled the CM from primed hASCs to increase EMT, cell migration, and uPA expression in MCF‐7 cells. Obtained data suggested that IFN‐γ and/or TNF‐α primed hASCs might enhance the malignancy of MCF‐7 cell line by inducing EMT, cell motility and uPA expression in these cells via TGF‐β1‐Smad3 signalization, with potentially important implications in breast cancer progression. © 2016 IUBMB Life, 68(3):190–200, 2016

23 October 2013 in Cell Biology International
Verified
Journal Article
Closed access
PDF file
Drenka TrivanovićDrenka Trivanović
Drenka Trivanović
SNSrdjan Nikolić
Srdjan Nikolić
Jelena KrsticJelena Krstic
Jelena Krstic
AJAleksandra Jaukovic
Aleksandra Jaukovic
SMSlavko Mojsilović
Slavko Mojsilović
DBDiana S. Bugarski
Diana S. Bugarski

10 December 2011 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
SMSlavko B. Mojsilovic
Slavko B. Mojsilovic
AKAleksandra Krstić
Aleksandra Krstić
Vesna IlićVesna Ilić
Vesna Ilić
IĐIvana Okić Đorđević
Ivana Okić Đorđević
JKJelena Kocić
Jelena Kocić
DBDiana Bugarski
Diana Bugarski